To access this element change to forms mode OFF
Grant Award View - GA332279
Cognitive-motor step training to reduce chemotherapy-induced peripheral...
GA ID:
GA332279
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
8-May-2023
Publish Date:
22-Aug-2023
Category:
Medical Research
Grant Term:
1-Jul-2023 to 30-Jun-2026
Value (AUD):
$808,942.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 22/23 1.1 Health and Medical Research
Grant Program:
Clinical Trials and Cohort Studies
Grant Activity:
Cognitive-motor step training to reduce chemotherapy-induced peripheral neuropathy (CIPN) symptoms in cancer survivors
Purpose:
Chemotherapy-induced peripheral neuropathy (CIPN) is a common and disabling side-effect in many cancers. Our trial will test whether a four-month rehabilitation program targeting balance and cognition, commonly impaired in cancer survivors with CIPN, can reduce symptoms and improve balance and quality of life. This highly scalable intervention has potential to accelerate access to effective rehabilitation for cancer survivors with CIPN to regain everyday function and live well in remission.
GO ID:
GO Title:
NHMRC Clinical Trials and Cohort Studies Grants 2022 for funding mid-2023
Internal Reference ID:
2023/GNT2023730
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Kensington
Town/City:
Kensington
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, SA, QLD
Postcode:
Multiple
Country:
AUSTRALIA